Watch Demo

Latvia Digestive System Disorder Industry Outlook 2022 - 2026

See how Latvia Digestive System Disorder performed compared to key markets such as Germany, Japan and South Korea.

Key Market Indicators

Sales of digestive system disorder medicines in Latvia are set to reach nearly $78 million by 2026, according to research. The market increased by an average of 4.9% annually between 2006 and 2021, reaching $69.1 million in 2021, making Latvia the 25th largest market globally. Slovenia was the largest in the region, with $69.1 million in sales. Japan, South Korea and Canada followed, in second, third and fourth place.

Marketing Banner

Latvia Digestive System Disorder Market Data and Forecasts

How much will Latvia Digestive System Disorder Market grow to 2026?

Forecast: Alimentary Tract and Metabolism Medicine Sales in Latvia
Forecast: Peptic Ulcer and Gastro-Oesophageal Reflux Diseases (GORD) Medicine Use in Latvia
Forecast: Alimentary Tract and Metabolism Medicine Sales in Latvia
Forecast: Alimentary Tract and Metabolism Medicine Sales in Latvia
More in Digestive System Disorder Industry for 2028